Annual Operating Profit
-$126.50 M
-$136.00 K-0.11%
31 December 2023
Summary:
Syros Pharmaceuticals annual operaing income is currently -$126.50 million, with the most recent change of -$136.00 thousand (-0.11%) on 31 December 2023. During the last 3 years, it has fallen by -$44.20 million (-53.71%). SYRS annual operating profit is now -841.56% below its all-time high of -$13.44 million, reached on 31 December 2014.SYRS Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Profit
-$26.18 M
+$1.23 M+4.50%
30 September 2024
Summary:
Syros Pharmaceuticals quarterly operating income is currently -$26.18 million, with the most recent change of +$1.23 million (+4.50%) on 30 September 2024. Over the past year, it has increased by +$6.10 million (+18.90%). SYRS quarterly operating profit is now -472.66% below its all-time high of -$4.57 million, reached on 31 March 2015.SYRS Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Operating Profit
-$111.52 M
+$6.10 M+5.19%
30 September 2024
Summary:
Syros Pharmaceuticals TTM operating income is currently -$111.52 million, with the most recent change of +$6.10 million (+5.19%) on 30 September 2024. Over the past year, it has increased by +$23.97 million (+17.69%). SYRS TTM operating profit is now -2339.28% below its all-time high of -$4.57 million, reached on 31 March 2015.SYRS TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SYRS Operating Profit Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -0.1% | +18.9% | +17.7% |
| 3 y3 years | -53.7% | +2.7% | -8.1% |
| 5 y5 years | -96.7% | -28.4% | -46.4% |
SYRS Operating Profit High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -53.7% | at low | -3.0% | +27.3% | -12.2% | +17.7% |
| 5 y | 5 years | -96.7% | at low | -56.4% | +27.3% | -52.3% | +17.7% |
| alltime | all time | -841.6% | at low | -472.7% | +27.3% | -2339.3% | +17.7% |
Syros Pharmaceuticals Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$26.18 M(-4.5%) | -$111.52 M(-5.2%) |
| June 2024 | - | -$27.42 M(-11.3%) | -$117.62 M(-5.3%) |
| Mar 2024 | - | -$30.92 M(+14.5%) | -$124.21 M(-1.8%) |
| Dec 2023 | -$126.50 M(+0.1%) | -$27.00 M(-16.3%) | -$126.50 M(-6.6%) |
| Sept 2023 | - | -$32.28 M(-5.1%) | -$135.49 M(+1.8%) |
| June 2023 | - | -$34.00 M(+2.4%) | -$133.15 M(+0.2%) |
| Mar 2023 | - | -$33.21 M(-7.7%) | -$132.92 M(+5.2%) |
| Dec 2022 | -$126.36 M(+27.1%) | -$36.00 M(+20.2%) | -$126.36 M(+9.1%) |
| Sept 2022 | - | -$29.94 M(-11.3%) | -$115.79 M(+2.7%) |
| June 2022 | - | -$33.77 M(+26.7%) | -$112.76 M(+7.3%) |
| Mar 2022 | - | -$26.65 M(+4.8%) | -$105.13 M(+5.7%) |
| Dec 2021 | -$99.42 M(+20.8%) | -$25.42 M(-5.5%) | -$99.42 M(-3.7%) |
| Sept 2021 | - | -$26.91 M(+2.9%) | -$103.22 M(+8.3%) |
| June 2021 | - | -$26.14 M(+24.8%) | -$95.30 M(+10.9%) |
| Mar 2021 | - | -$20.94 M(-28.3%) | -$85.90 M(+4.4%) |
| Dec 2020 | -$82.30 M(+5.9%) | -$29.22 M(+53.8%) | -$82.30 M(+12.4%) |
| Sept 2020 | - | -$19.00 M(+13.5%) | -$73.25 M(-1.9%) |
| June 2020 | - | -$16.74 M(-3.4%) | -$74.64 M(-4.4%) |
| Mar 2020 | - | -$17.34 M(-14.0%) | -$78.11 M(+0.5%) |
| Dec 2019 | -$77.74 M | -$20.17 M(-1.1%) | -$77.74 M(+2.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2019 | - | -$20.39 M(+0.9%) | -$76.18 M(+5.6%) |
| June 2019 | - | -$20.21 M(+19.1%) | -$72.11 M(+8.5%) |
| Mar 2019 | - | -$16.97 M(-8.8%) | -$66.45 M(+3.3%) |
| Dec 2018 | -$64.30 M(+17.6%) | -$18.61 M(+14.0%) | -$64.30 M(+5.0%) |
| Sept 2018 | - | -$16.32 M(+12.2%) | -$61.21 M(+3.9%) |
| June 2018 | - | -$14.55 M(-1.8%) | -$58.93 M(+1.8%) |
| Mar 2018 | - | -$14.82 M(-4.5%) | -$57.89 M(+5.9%) |
| Dec 2017 | -$54.69 M(+14.0%) | -$15.52 M(+10.5%) | -$54.69 M(+8.9%) |
| Sept 2017 | - | -$14.04 M(+3.9%) | -$50.21 M(-0.4%) |
| June 2017 | - | -$13.51 M(+16.4%) | -$50.39 M(+3.0%) |
| Mar 2017 | - | -$11.61 M(+5.1%) | -$48.94 M(+2.0%) |
| Dec 2016 | -$47.96 M(+60.8%) | -$11.04 M(-22.3%) | -$47.96 M(+0.7%) |
| Sept 2016 | - | -$14.22 M(+17.8%) | -$47.61 M(+13.7%) |
| June 2016 | - | -$12.06 M(+13.4%) | -$41.85 M(+16.6%) |
| Mar 2016 | - | -$10.64 M(-0.5%) | -$35.88 M(+20.3%) |
| Dec 2015 | -$29.82 M(+122.0%) | -$10.69 M(+26.3%) | -$29.82 M(+55.9%) |
| Sept 2015 | - | -$8.46 M(+38.9%) | -$19.13 M(+79.3%) |
| June 2015 | - | -$6.09 M(+33.3%) | -$10.67 M(+133.3%) |
| Mar 2015 | - | -$4.57 M | -$4.57 M |
| Dec 2014 | -$13.44 M | - | - |
FAQ
- What is Syros Pharmaceuticals annual operaing income?
- What is the all time high annual operating profit for Syros Pharmaceuticals?
- What is Syros Pharmaceuticals annual operating profit year-on-year change?
- What is Syros Pharmaceuticals quarterly operating income?
- What is the all time high quarterly operating profit for Syros Pharmaceuticals?
- What is Syros Pharmaceuticals quarterly operating profit year-on-year change?
- What is Syros Pharmaceuticals TTM operating income?
- What is the all time high TTM operating profit for Syros Pharmaceuticals?
- What is Syros Pharmaceuticals TTM operating profit year-on-year change?
What is Syros Pharmaceuticals annual operaing income?
The current annual operating profit of SYRS is -$126.50 M
What is the all time high annual operating profit for Syros Pharmaceuticals?
Syros Pharmaceuticals all-time high annual operaing income is -$13.44 M
What is Syros Pharmaceuticals annual operating profit year-on-year change?
Over the past year, SYRS annual operaing income has changed by -$136.00 K (-0.11%)
What is Syros Pharmaceuticals quarterly operating income?
The current quarterly operating profit of SYRS is -$26.18 M
What is the all time high quarterly operating profit for Syros Pharmaceuticals?
Syros Pharmaceuticals all-time high quarterly operating income is -$4.57 M
What is Syros Pharmaceuticals quarterly operating profit year-on-year change?
Over the past year, SYRS quarterly operating income has changed by +$6.10 M (+18.90%)
What is Syros Pharmaceuticals TTM operating income?
The current TTM operating profit of SYRS is -$111.52 M
What is the all time high TTM operating profit for Syros Pharmaceuticals?
Syros Pharmaceuticals all-time high TTM operating income is -$4.57 M
What is Syros Pharmaceuticals TTM operating profit year-on-year change?
Over the past year, SYRS TTM operating income has changed by +$23.97 M (+17.69%)